Legal Representation
Attorney
Nancy Sabarra
USPTO Deadlines
Next Deadline
148 days remaining
NOA E-Mailed - SOU Required
Due Date
May 16, 2026
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 19, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 16, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 15, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 15, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 15, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 5, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 5, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 15, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 15, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 17, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 16, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 16, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 24, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
vaccines; vaccines for human use; flu vaccines
Class 042
Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
Class 044
Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CELL-BASED ADJUVANT TECHNOLOGY"